Safety and efficacy of restarting immune checkpoint inhibitors after immune-related adverse events
Immune checkpoint inhibitors can cause a number of immune-related adverse [...]
Assessing and managing adverse events to immunotherapies
In this video interview, Brenda Martone discusses the clinical nurse [...]
IKCS 2019: Immune related adverse events
Dr Mehmet Asim Bilen of Emory University School of Medicine [...]
ASCO 2019: Safety and efficacy of immune checkpoint inhibitors in patients with pre-existing autoimmune disorders
This study was presented at the American Society of Clinical [...]
Immune-related adverse events to nivolumab associated with survival
A real-world study recently reported in Journal for Immunotherapy of [...]
Treatment-related hyperprogression
The following article from Cancer Therapy Advisor presents the arguments for [...]
Managing immune-related adverse events
Immune-related adverse events (irAEs) are side effects that can develop [...]
